GlassScriptPhysician profile
James D Hardie
NPI 1497811327
$2,771.48
in general payments reported to CMS, 2019-2025
14 companies · $1,194 in 2025
The $1,194 reported for 2025 was more than what 99% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $652 · 2024: $926 · 2025: $1,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,771.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $672.03 | 2023-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $604.44 | 2023-2025 | Entyvio, Eohilia, Gattex |
| Janssen Biotech, INC. | $602.65 | 2023-2025 | Tremfya, Stelara, Simponi |
| Abbvie INC. | $550.23 | 2024-2025 | |
| Lilly USA, LLC | $67.79 | 2024-2025 | Omvoh, Zepbound |
| Intercept Pharmaceuticals, INC. | $63.39 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $58.28 | 2024 | Dificid |
| Nestle Healthcare Nutrition INC. | $39.73 | 2023 | |
| Madrigal Pharmaceuticals | $23.99 | 2025 | Rezdiffra |
| Ardelyx, INC. | $23.68 | 2025 | Ibsrela |
| Masimo Corporation | $19.46 | 2024 | Set and Rainbow Set |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.51 | 2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $14.77 | 2024 | Voquezna |
| Aimmune Therapeutics, INC. | $14.53 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hardie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.